Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Lipid-Lowering Agents - Bahrain

Bahrain
  • The market of Lipid-Lowering Agents market in Bahrain is expected to witness a significant growth in revenue.
  • By the year 2024, the projected revenue is estimated to reach US$1.14m.
  • This growth is further expected to continue at an annual growth rate (CAGR 2024-2029) of 0.04%.
  • As a result, the market volume is anticipated to reach US$1.14m by the year 2029.
  • When compared globally, it is noteworthy that United States is expected to generate the highest revenue in this market.
  • In 2024, the revenue generated United States is projected to be a staggering US$4.46bn.
  • The use of lipid-lowering agents is on the rise in Bahrain as the country experiences a growing prevalence of cardiovascular diseases.

Definition:
The Lipid-Lowering Agents market covers drugs to treat hyperlipidemia or dyslipidemia. These metabolic disorders are characterized by high levels of lipids, such as fats, cholesterol, or triglycerides, or lipoproteins in the blood. Different drug classes are included: statins, PCSK9 inhibitors, bile acid sequestrants, cholesterol absorption inhibitors, fibric acid derivatives, as well as combinations thereof.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Merck & Co., AstraZeneca, Viatris

In-Scope

  • Anti-hyperlipidemics
  • Drugs to treat high levels of lipids in the blood
  • Cholesterol-lowering drugs

Out-Of-Scope

  • Anti-diabetes drugs
  • Drugs to treat other metabolic disorders
  • Dietary supplements
Lipid-Lowering Agents: market data & analysis - Cover

Market Insights report

Lipid-Lowering Agents: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    Bahrain, a small island nation in the Arabian Gulf, has a growing demand for Lipid-Lowering Agents.

    Customer preferences:
    The population of Bahrain is becoming increasingly health-conscious, with a focus on preventive health measures. This has led to a rise in demand for Lipid-Lowering Agents, which are used to treat high cholesterol levels. The majority of the population in Bahrain is Muslim, and as such, there is a preference for Halal-certified medications.

    Trends in the market:
    The market for Lipid-Lowering Agents in Bahrain is growing steadily, driven by an increase in the prevalence of lifestyle diseases such as obesity and diabetes. The government of Bahrain has launched several initiatives to promote healthy living, including the introduction of a sugar tax and the implementation of a national health insurance system. These initiatives are expected to further boost the demand for Lipid-Lowering Agents in the coming years.

    Local special circumstances:
    Bahrain has a small population of just over 1.5 million people, which limits the size of the Lipid-Lowering Agents market. However, the country's high-income economy and relatively high prevalence of lifestyle diseases make it an attractive market for pharmaceutical companies. Additionally, the government of Bahrain has implemented policies to attract foreign investment, which has led to the establishment of several multinational pharmaceutical companies in the country.

    Underlying macroeconomic factors:
    Bahrain's economy is heavily dependent on oil exports, which account for over 70% of government revenue. The recent decline in oil prices has had a negative impact on the country's economy, leading to a reduction in government spending. However, the government has implemented several measures to diversify the economy and reduce its reliance on oil, including the development of the healthcare sector. This has led to increased investment in healthcare infrastructure and the establishment of several medical facilities in the country.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Lipid-Lowering Agents: market data & analysis - BackgroundLipid-Lowering Agents: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.